BNTX
Price
$112.44
Change
+$8.94 (+8.64%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
24.88B
59 days until earnings call
SMMT
Price
$25.99
Change
+$2.19 (+9.20%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
19.3B
61 days until earnings call
Interact to see
Advertisement

BNTX vs SMMT

Header iconBNTX vs SMMT Comparison
Open Charts BNTX vs SMMTBanner chart's image
BioNTech SE American Depositary Share
Price$112.44
Change+$8.94 (+8.64%)
Volume$17.11K
Capitalization24.88B
Summit Therapeutics
Price$25.99
Change+$2.19 (+9.20%)
Volume$61.79K
Capitalization19.3B
BNTX vs SMMT Comparison Chart in %
Loading...
BNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BNTX vs. SMMT commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNTX is a Hold and SMMT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (BNTX: $103.50 vs. SMMT: $23.80)
Brand notoriety: BNTX and SMMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BNTX: 113% vs. SMMT: 86%
Market capitalization -- BNTX: $24.88B vs. SMMT: $19.3B
BNTX [@Biotechnology] is valued at $24.88B. SMMT’s [@Biotechnology] market capitalization is $19.3B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNTX’s FA Score shows that 2 FA rating(s) are green whileSMMT’s FA Score has 1 green FA rating(s).

  • BNTX’s FA Score: 2 green, 3 red.
  • SMMT’s FA Score: 1 green, 4 red.
According to our system of comparison, SMMT is a better buy in the long-term than BNTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNTX’s TA Score shows that 5 TA indicator(s) are bullish while SMMT’s TA Score has 3 bullish TA indicator(s).

  • BNTX’s TA Score: 5 bullish, 6 bearish.
  • SMMT’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, BNTX is a better buy in the short-term than SMMT.

Price Growth

BNTX (@Biotechnology) experienced а +1.54% price change this week, while SMMT (@Biotechnology) price change was -2.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.44%. For the same industry, the average monthly price growth was +9.90%, and the average quarterly price growth was +31.78%.

Reported Earning Dates

BNTX is expected to report earnings on Nov 03, 2025.

SMMT is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BNTX($24.9B) has a higher market cap than SMMT($19.3B). BNTX has higher P/E ratio than SMMT: BNTX (161.76) vs SMMT (26.36). SMMT YTD gains are higher at: 33.371 vs. BNTX (-9.171). BNTX has higher annual earnings (EBITDA): -72.1M vs. SMMT (-743.48M). BNTX has more cash in the bank: 14B vs. SMMT (298M). SMMT has less debt than BNTX: SMMT (5.55M) vs BNTX (270M). BNTX has higher revenues than SMMT: BNTX (2.88B) vs SMMT (0).
BNTXSMMTBNTX / SMMT
Capitalization24.9B19.3B129%
EBITDA-72.1M-743.48M10%
Gain YTD-9.17133.371-27%
P/E Ratio161.7626.36614%
Revenue2.88B0-
Total Cash14B298M4,698%
Total Debt270M5.55M4,862%
FUNDAMENTALS RATINGS
BNTX vs SMMT: Fundamental Ratings
BNTX
SMMT
OUTLOOK RATING
1..100
5767
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
95
Overvalued
PROFIT vs RISK RATING
1..100
9243
SMR RATING
1..100
92100
PRICE GROWTH RATING
1..100
6246
P/E GROWTH RATING
1..100
19
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BNTX's Valuation (3) in the null industry is significantly better than the same rating for SMMT (95) in the Biotechnology industry. This means that BNTX’s stock grew significantly faster than SMMT’s over the last 12 months.

SMMT's Profit vs Risk Rating (43) in the Biotechnology industry is somewhat better than the same rating for BNTX (92) in the null industry. This means that SMMT’s stock grew somewhat faster than BNTX’s over the last 12 months.

BNTX's SMR Rating (92) in the null industry is in the same range as SMMT (100) in the Biotechnology industry. This means that BNTX’s stock grew similarly to SMMT’s over the last 12 months.

SMMT's Price Growth Rating (46) in the Biotechnology industry is in the same range as BNTX (62) in the null industry. This means that SMMT’s stock grew similarly to BNTX’s over the last 12 months.

BNTX's P/E Growth Rating (1) in the null industry is in the same range as SMMT (9) in the Biotechnology industry. This means that BNTX’s stock grew similarly to SMMT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BNTXSMMT
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 24 days ago
76%
Bullish Trend 11 days ago
86%
Declines
ODDS (%)
Bearish Trend 8 days ago
80%
Bearish Trend 8 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ARMH58.551.64
+2.89%
ARM HOLDINGS PLC ADRHEDGED ARMH
XHS99.320.37
+0.38%
SPDR® S&P Health Care Services ETF
YEAR50.560.01
+0.01%
AB Ultra Short Income ETF
RFEU69.90N/A
N/A
First Trust RiverFront Dynamic Eurp ETF
TZA8.90-0.34
-3.68%
Direxion Daily Small Cap Bear 3X ETF

BNTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BNTX has been loosely correlated with SMMT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if BNTX jumps, then SMMT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNTX
1D Price
Change %
BNTX100%
+3.07%
SMMT - BNTX
52%
Loosely correlated
+1.19%
TIL - BNTX
52%
Loosely correlated
+4.55%
MRNA - BNTX
47%
Loosely correlated
+0.96%
KYMR - BNTX
47%
Loosely correlated
-2.54%
NVAX - BNTX
43%
Loosely correlated
+5.27%
More

SMMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SMMT has been closely correlated with BCDA. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if SMMT jumps, then BCDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMMT
1D Price
Change %
SMMT100%
+1.19%
BCDA - SMMT
70%
Closely correlated
N/A
TIL - SMMT
55%
Loosely correlated
+4.55%
BNTX - SMMT
52%
Loosely correlated
+3.07%
RLAY - SMMT
46%
Loosely correlated
-2.68%
VBIZF - SMMT
42%
Loosely correlated
N/A
More